RecruitingNCT06833632
Detection of Circulating Tumour Cells, Spread Through Air Space in Patients With Lung Cancer
Detection of Circulating Tumour Cells, Spread Through Air Space and Lymph-nodal Micrometastasis in Patients With Lung Cancer Undergoing Surgical Resection With Curative Intent
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Enrollment
100 participants
Start Date
May 25, 2023
Study Type
OBSERVATIONAL
Summary
The aim of this study is to evaluate the prognostic impact of the presence of circulating tumour cells Circulating Tumour Cells (CTCs), Spread Through Air Space (STAS) and lymph node micrometastases in patients undergoing radical surgery for non-small cell lung neoplasia
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- obtaining voluntary written informed consent
- diagnosis of NSCLC
- clinical stage I-IIA cN0
- Candidates for surgical resection
Exclusion Criteria6
- Pregnancy
- Induction therapy for pulmonary neoplasia
- Patients who have received systemic treatment for previous cancers in the last three years prior to lung surgery
- Any previous surgery for lung cancer
- Patients with other active neoplasms
- Infiltration of the chest wall
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06833632